Welcome!

Websphere Authors: Gilad Parann-Nissany, Liz McMillan, Yeshim Deniz, RealWire News Distribution, PR.com Newswire

News Feed Item

InterWest Partners Congratulates Bruce Cleveland and Doug Pepper on Being Named to AlwaysOn Venture Capital 100 List

MENLO PARK, CA -- (Marketwired) -- 02/07/14 -- InterWest Partners, a leading diversified venture capital firm, is pleased to congratulate two of its general partners, Bruce Cleveland and Doug Pepper, for being named to the AlwaysOn Venture Capital 100 List for 2013. The list recognizes the investors who have funded the best technology companies in the fields of digital entertainment, on-demand computing, cloud and infrastructure, and digital media.

AlwaysOn editors highlighted both partners' successful investment in Marketo, which went public last year, as the "Notable Exit" that contributed to their selection to the list.

InterWest's recent successful IT investments include Marketo, CubeTree (acquired by SuccessFactors), Epocrates and Virsto (acquired by VMWare). The firm's current IT investments include: AppMesh, Aria, Badgeville, Biba, C3 Energy, C9, Doximity, Flurry, Get Satisfaction, INVIDI, Mobee, NewsCred, Optimizely and Spredfast.

About AlwaysOn VC100
AlwaysOn editors compiled the 2013 VC 100 with help from our research partners at Morgan Stanley. The winning venture capitalists were selected based on total number and dollar amounts of successful M&A and IPO deals during the last two years (October 1, 2011 through September 30, 2013) from their portfolio companies. The AlwaysOn VC 100 will be honored at Venture Summit Silicon Valley at Draper University, San Mateo on February 13th.

About InterWest
For more than 30 years, InterWest has partnered with exceptional entrepreneurs to build winning technology and health care companies. With more than 200 years of combined operating and investing experience, the firm's investing team has raised $2.8B, completed more than 78 IPOs, and participated in nearly 75 upside acquisitions. As the firm invests InterWest X, a $650M fund, the InterWest team continues to believe that providing capital is just the beginning of a long-term collaboration with entrepreneurs to turn their vision into a thriving company.

The firm's past successful investments in information technology include: CIENA, Copper Mountain Networks, Crystal Semiconductor (acquired by Cirrus Logic), CubeTree (acquired by SuccessFactors), Cyrix (acquired by National Semiconductor), Edify (acquired by Security First Technologies), Epocrates, Kalpana (acquired by Cisco), Lightera (acquired by CIENA), Lombardi Software (acquired by IBM), Marketo, Network Computing Devices, Open Silicon (acquired by Unicorn Investment Bank), PlaceWare (acquired by Microsoft), Platform Solutions (acquired by IBM), Radius, Rendition (acquired by Micron Technology), Sierra Logic (acquired by Emulex), SiTera (acquired by Vitesse), Silicon Graphics, Stratacom (acquired by Cisco), Virsto (acquired by VMWare), Workday and Xilinx.

The firm's past successful investments in health care include: AkaRx (acquired by Eisai), Ammplimune (acquired by Astrazeneca), ArthroCare, Aspreva Pharmaceuticals (acquired by Galenica group), CNS Therapeutics (acquired by Covidien), Cor Therapeutics (acquired by Millennium Pharmaceuticals), Corixa Pharmaceuticals (acquired by GlaxoSmithKline), Coulter Pharmaceuticals (acquired by Corixa Pharmaceuticals), Cubist Pharmaceuticals, Epicor Medical (acquired by St. Jude Medical), Inspire Pharmaceuticals, IntraLase (acquired by Advanced Medical Optics), Kai Pharmaceuticals (acquired by Amgen), LenSx Lasers (acquired by Alcon), Myogen (acquired by Gilead), Nanostim (acquired by St. Jude Medical) NovaCardia (acquired by Merck), Spinal Dynamics (acquired by Medtronic), TheraSense (acquired by Abbott Labs), Trius (acquired by Cubist) and Ventritex (acquired by St. Jude Medical).

Eliot Dobris
Cell: 415 902-1241
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.